UCSD is Natl. Study Site for Cancer Immunotherapy
Wednesday, April 13, 2011 - 12:50
in Health & Medicine
The University of California, San Diego School of Medicine is among 27 research institutions selected across North America to be a part of the Cancer Immunotherapy Trials Network (CITN), funded by the National Cancer Institute (NCI). The CITN will establish a network of top academic immunologists to conduct multicenter research on agents that boost patients' own immune systems to fight their cancer.